Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-cirrhotic, Chronic Hepatitis B”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableLooking for participantsNCT05195450
What this trial is testing

TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

Who this might be right for
Non-cirrhotic, Chronic Hepatitis B
Institute of Liver and Biliary Sciences, India 200
Early research (Phase 1)WithdrawnNCT05867056
What this trial is testing

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Immunocore Ltd
Early research (Phase 1)Ended earlyNCT02826018
What this trial is testing

ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis BChronic Hepatitis BHepatitis B, Chronic+2 more
Alnylam Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT01277601
What this trial is testing

Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 751
Testing effectiveness (Phase 2)Ended earlyNCT04059198
What this trial is testing

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Who this might be right for
Hepatitis BHBVHepatitis B, Chronic
F-star Therapeutics, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT04023721
What this trial is testing

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor

Who this might be right for
Hepatitis BHBVHepatitis B, Chronic
F-star Therapeutics, Inc. 64
Testing effectiveness (Phase 2)Study completedNCT02631096
What this trial is testing

Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy

Who this might be right for
Hepatitis B, Chronic
Arbutus Biopharma Corporation 36